A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers

BACKGROUND: Patients with advanced endocrine cancers, such as adrenocortical carcinoma and medullary thyroid carcinoma, have few well-validated therapeutic options. Pre-clinical studies have suggested potential activity of imatinib in these tumors. We therefore sought to establish a safe, novel trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Halperin, Daniel M, Phan, Alexandria T, Hoff, Ana O, Aaron, Marie, Yao, James C, Hoff, Paulo M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125701/
https://www.ncbi.nlm.nih.gov/pubmed/25086465
http://dx.doi.org/10.1186/1471-2407-14-561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125701/
https://www.ncbi.nlm.nih.gov/pubmed/25086465
http://dx.doi.org/10.1186/1471-2407-14-561

Ejemplares similares